The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize ...

Interventionalists don’t often order a CXR ahead of time, but when it’s already been done, some find the added info useful.

No one can predict what the medical device industry will look like in 2026. Still, the events of 2025 provide meaningful ...

This case report describes a man in the late 60s with stage IV, RAS-mutated colorectal cancer with the bilobar liver metastasis, planned for a two-stage hepatectomy. Following right hemicolectomy and ...

A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

When I was about 6 years old in the early ‘40s, my 16-year-old brother was sent to a sanitarium for tuberculosis patients. He ...

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...

An unfortunate characteristic of the adult mammalian heart is its ineffective use of programs for repair and regeneration, especially after acute coronary occlusion and ST-elevation myocardial ...

Using 21 st century diagnostics to overcome barriers for lung function testing in primary care: it is time to consider oscillometry Obstructive airways diseases, including asthma and COPD as the most ...